Tailored Antiplatelet Therapy Following PCI



Status:Enrolling by invitation
Conditions:Peripheral Vascular Disease, Cardiology
Therapuetic Areas:Cardiology / Vascular Diseases
Healthy:No
Age Range:18 - Any
Updated:2/8/2019
Start Date:May 2013
End Date:March 2020

Use our guide to learn which trials are right for you!

Tailored Antiplatelet Initiation to Lesson Outcomes Due to Decreased Clopidogrel Response After Percutaneous Coronary Intervention (TAILOR-PCI)

Clopidogrel is an anti-platelet medication approved by the U.S. Federal Drug Administration
(FDA) for use in patients who undergo Percutaneous Coronary Intervention (PCI) with coronary
stent implantation. Anti-platelet medications work to prevent blood clots from forming. Some
studies have suggested that patients who have a certain genetic liver enzyme abnormality
(known as cytochrome P450 2C19 [CYP2C19] *2 or *3 allele) may have a reduced ability to
activate clopidogrel, and therefore may have a lowered response to clopidogrel. It is thought
that perhaps people who have a coronary stent procedure may have this genetic liver enzyme
abnormality. There is a research genetic test available to determine whether or not someone
has this genetic liver enzyme abnormality. Ticagrelor, is a newer anti-platelet drug that is
not dependent on the CYP2C19 liver enzyme for its activation and hence in poor clopidogrel
metabolizers, alternative drugs like Ticagrelor have been recommended for use as an
anti-platelet agent after PCI. The purpose of this study is to determine if genetic testing
can identify the best anti-platelet therapy, for patients who undergo a coronary stent
placement and do not activate clopidogrel very well.

TAILOR-PCI is a multi-site, open label, prospective, randomized trial testing the hypothesis
that after percutaneous coronary intervention (PCI), using a genotyping strategy ticagrelor
90 mg twice per day is superior to clopidogrel 75 mg per day in reducing a composite endpoint
of major adverse cardiovascular events (MACE), i.e., non-fatal myocardial infarction,
non-fatal stroke, severe recurrent ischemia, cardiovascular (CV) death, and stent thrombosis
(primary endpoints) in CYP2C19 reduced function allele patients. Patients who undergo PCI
will be randomized to a conventional therapy arm (i.e., to receive clopidogrel 75 mg once
daily without prospective genotyping guidance) versus a prospective CYP2C19 genotype-based
anti-platelet therapy approach (ticagrelor 90 mg bid in CYP2C19 *2 or *3 reduced function
allele patients, clopidogrel 75 mg once daily in non-*2 or -*3 CYP2C19 patients). Buccal
swabs will be obtained for those subjects randomized to the prospective genotyping arm. All
subjects will have a blood sample drawn for DNA analysis but genotyping using these DNA
samples will be performed only after completion of the duration of anti-platelet therapy
(i.e., after one year). The primary endpoints will be assessed prospectively and will be
compared between the conventional arm and the prospective genotyping arm among those
identified as reduced function CYP2C19 allele carriers according to the 1-year genotype
results.

Inclusion

- Patient >18 years of age

- Patient presents with acute coronary syndrome (ACS) or stable coronary artery disease
(CAD)

- Patient is eligible for PCI

- Patient is willing and able to provide informed written consent

5.3 Exclusion

- Patient not able to receive 12 months of dual anti-platelet therapy

- Failure of index PCI

- Patient or physician refusal to enroll in the study

- Patient with known CYP2C19 genotype prior to randomization

- Planned revascularization of any vessel within 30 days post-index procedure and/or of
the target vessel(s) within 12 months post-procedure

- Anticipated discontinuation of clopidogrel or ticagrelor within the 12 month follow up
period, example for elective surgery

- Serum creatinine >2.5 mg/dL within 7 days of index procedure

- Platelet count <80,000 or >700,000 cells/mm3, or white blood cell count <3,000
cells/mm3 if persistent (at least 2 abnormal values) within 7 days prior to index
procedure.

- History of intracranial hemorrhage

- Known hypersensitivity to clopidogrel or ticagrelor or any of its components

- Patient is participating in an investigational drug or device clinical trial that has
not reached its primary endpoint

- Patient previously enrolled in this study

- Patient is pregnant, lactating, or planning to become pregnant within 12 months

- Patient has received an organ transplant or is on a waiting list for an organ
transplant

- Patient is receiving or scheduled to receive chemotherapy within 30 days before or
after the procedure

- Patient is receiving immunosuppressive therapy or has known immunosuppressive or
autoimmune disease (e.g., human immunodeficiency virus, systemic lupus erythematous,
etc.)

- Patient is receiving chronic oral anticoagulation therapy (i.e., vitamin K antagonist,
direct thrombin inhibitor, Factor Xa inhibitor)

- Concomitant use of simvastatin/lovastatin > 40 mg qd

- Concomitant use of potent CYP3A4 inhibitors (atazanavir, clarithromycin, indinavir,
itraconazole, ketoconazole, nefazodone, nelfinavir, ritonavir, saquinavir,
telithromycin and voriconazole) or inducers (carbamazepine, dexamethasone,
phenobarbital, phenytoin, rifampin, and rifapentine)

- Non-cardiac condition limiting life expectancy to less than one year, per physician
judgment (e.g. cancer)

- Known history of severe hepatic impairment

- Patient has a history of bleeding diathesis or coagulopathy or will refuse blood
transfusions

- Patient has an active pathological bleeding, such as active gastrointestinal (GI)
bleeding

- Inability to take aspirin at a dosage of 100 mg or less

- Current substance abuse (e.g., alcohol, cocaine, heroin, etc.)
We found this trial at
27
sites
164 Summit Ave
Providence, Rhode Island 02906
(401) 793-2500
Principal Investigator: Paul Gordon, MD
Phone: 401-793-4105
Miriam Hospital The Miriam Hospital is a private, not-for-profit hospital, with a history of providing...
?
mi
from
Providence, RI
Click here to add this to my saved trials
2500 N State St
Jackson, Mississippi 39216
(601) 984-1000
Principal Investigator: Cameron S Guild, MD
Phone: 601-984-5678
University of Mississippi Medical Center The University of Mississippi Medical Center, located in Jackson, is...
?
mi
from
Jackson, MS
Click here to add this to my saved trials
Minneapolis, Minnesota 55455
(612) 625-5000
Principal Investigator: Ganesh Raveendran, MN
Phone: 612-626-3656
Univ of Minnesota With a flagship campus in the heart of the Twin Cities, and...
?
mi
from
Minneapolis, MN
Click here to add this to my saved trials
593 Eddy Street
Providence, Rhode Island 02903
401-444-4000
Principal Investigator: Dawn Abbott
Phone: 401-793-4105
Rhode Island Hospital Founded in 1863, Rhode Island Hospital in Providence, RI, is a private,...
?
mi
from
Providence, RI
Click here to add this to my saved trials
47 New Scotland Ave
Albany, New York 12208
(518) 262-3125
Principal Investigator: Mohammed El-Hajjar, MD
Phone: 518-262-9316
Albany Medical College Albany Medical Center is northeastern New York's only academic health sciences center...
?
mi
from
Albany, NY
Click here to add this to my saved trials
Crestview Hills, Kentucky 41017
Principal Investigator: DP Suresh, MD
Phone: 859-301-4725
?
mi
from
Crestview Hills, KY
Click here to add this to my saved trials
2799 W Grand Blvd
Detroit, Michigan 48202
(313) 916-2600
Principal Investigator: Khaled Nour, MD
Phone: 313-916-3613
Henry Ford Hospital Founded in 1915 by auto pioneer Henry Ford and now one of...
?
mi
from
Detroit, MI
Click here to add this to my saved trials
Duluth, Minnesota 55805
Principal Investigator: Wilson Ginete, MD
?
mi
from
Duluth, MN
Click here to add this to my saved trials
Eau Claire, Wisconsin 54702
Principal Investigator: Fearghas O'Cochlain, MD
Phone: 715-464-8131
?
mi
from
Eau Claire, WI
Click here to add this to my saved trials
Evanston, Illinois 60201
Principal Investigator: Jorge Saucedo, M.D.
Phone: 847-570-1997
?
mi
from
Evanston, IL
Click here to add this to my saved trials
Greenville, South Carolina 29615
Principal Investigator: Josh R Doll, MD, FACC
Phone: 864-455-7793
?
mi
from
Greenville, SC
Click here to add this to my saved trials
4500 San Pablo Rd S
Jacksonville, Florida 32224
(904) 953-2000
Principal Investigator: Gary E Lane, MD
Phone: 904-953-3882
Mayo Clinic Florida Thousands of people come to Mayo Clinic in Jacksonville, Fla., annually for...
?
mi
from
Jacksonville, FL
Click here to add this to my saved trials
700 West Avenue South
La Crosse, Wisconsin 54601
Principal Investigator: Charles R Cagin, DO
?
mi
from
La Crosse, WI
Click here to add this to my saved trials
?
mi
from
Manhasset, NY
Click here to add this to my saved trials
2160 South 1st Avenue
Maywood, Illinois 60153
(888) 584-7888
Principal Investigator: Amir Darki, MD
Phone: 708-327-2761
Loyola University Medical Center Loyola University Health System is committed to excellence in patient care...
?
mi
from
Maywood, IL
Click here to add this to my saved trials
Milwaukee, Wisconsin 53215
Phone: 414-649-3490
?
mi
from
Milwaukee, WI
Click here to add this to my saved trials
259 1st St
Mineola, New York 11501
(516) 663-0333
Principal Investigator: Kevin Marzo, MD, FACC
Phone: 516-663-2929
Winthrop University Hospital Founded in 1896 by a group of local physicians and concerned citizens,...
?
mi
from
Mineola, NY
Click here to add this to my saved trials
Minneapolis, Minnesota 55407
Principal Investigator: Ivan J Chavez, MD
Phone: 612-863-3895
?
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Naples, Florida 34102
Principal Investigator: Adam Frank, M.D.
Phone: 239-624-4242
?
mi
from
Naples, FL
Click here to add this to my saved trials
550 1st Ave
New York, New York 10016
(212) 263-7300
Principal Investigator: Louai Razzouk, MD
Phone: 212-263-4016
New York University Langone Medical Center NYU NYU Langone Medical Center, a world-class, patient-centered, integrated,...
?
mi
from
New York, NY
Click here to add this to my saved trials
630 W 168th St
New York, New York
212-305-2862
Principal Investigator: Tamim Nazif, MD
Phone: 347-514-3366
Columbia University Medical Center Situated on a 20-acre campus in Northern Manhattan and accounting for...
?
mi
from
New York, NY
Click here to add this to my saved trials
200 First Street SW
Rochester, Minnesota 55905
507-284-2511
Principal Investigator: Malcolm Bell, MD
Mayo Clinic Rochester Mayo Clinic is a nonprofit worldwide leader in medical care, research and...
?
mi
from
Rochester, MN
Click here to add this to my saved trials
San Diego, California 32123
Principal Investigator: Ronald Goldberg, MD
Phone: 619-823-7347
?
mi
from
San Diego, CA
Click here to add this to my saved trials
1001 Potrero Avenue
San Francisco, California 94110
Principal Investigator: Alan Wu, MD
Phone: 415-206-4239
?
mi
from
San Francisco, CA
Click here to add this to my saved trials
Schenectady, New York 12309
Principal Investigator: Steven Weitz, MD
Phone: 518-377-8184
?
mi
from
Schenectady, NY
Click here to add this to my saved trials
13400 E. Shea Blvd.
Scottsdale, Arizona 85259
480-301-8000
Principal Investigator: John Sweeney, MD
Phone: 480-342-1248
Mayo Clinic Arizona Mayo Clinic in Arizona provides medical care for thousands of people from...
?
mi
from
Scottsdale, AZ
Click here to add this to my saved trials
Vancouver, British Columbia
Principal Investigator: Jacqueline Saw, MD
Phone: 604-875-5106
?
mi
from
Vancouver,
Click here to add this to my saved trials